Myelin oligodendrocyte glycoprotein antibodies (MOG-abs) have been recently detected in patients with various types of acquired demyelinating syndromes, including ADEM (Hennes et al., 2017), and have become a hot topic of research. This evidence concerns the gene MOG and acute disseminated encephalomyelitis.